Rabeprazole · Aciphex

Small molecule

Approvedregulatory verdict

Evidence outlook

Approved: Helicobacter pylori Infection

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

Every registered study for this drug was reviewed, and none was selected as featured evidence for its approved use, so its Featured trials section is empty.

Also approved (5)
US
  • Healing of Erosive or Ulcerative GERD in Adults ACIPHEX delayed-release tablets are indicated for short-term (4 to 8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (GERD). For those patients who have not healed after 8 weeks of treatment, an additional 8-week course of ACIPHEX may be considered.
  • Maintenance of Healing of Erosive or Ulcerative GERD in Adults ACIPHEX delayed-release tablets are indicated for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative gastroesophageal reflux disease (GERD Maintenance). Controlled studies do not extend beyond 12 months.
  • Helicobacter pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence in Adults ACIPHEX delayed-release tablets, in combination with amoxicillin and clarithromycin as a three drug regimen, are indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or history within the past 5 years) to eradicate H. pylori . Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence. In patients who fail therapy, susceptibility testing should be done. If resistance to clarithromycin is demonstrated or susceptibility testing is n
  • Pathological Hypersecretory Conditions, Including Zollinger-Ellison Syndrome ( 1.6 ). In adolescent patients 12 years of age and older for: Short-term Treatment of Symptomatic GERD
  • Healing of Duodenal Ulcers in Adults ACIPHEX delayed-release tablets are indicated for short-term (up to four weeks) treatment in the healing and symptomatic relief of duodenal ulcers. Most patients heal within four weeks.
Product first approved 2002Outside this platform's coverageFDA label

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (25)
Other / comorbidity
NCT07608536 · King George's Medical University
2026-05-01 – 2026-07-31 · Endoscopic Variceal Band Ligation
What this study did
NCT05857163 · TenNor Therapeutics (Suzhou) Limited
2023-05-18 – 2024-03-26 · H.Pylori Infection
What this study did
NCT01408186 · Chinese University of Hong Kong
2011-01 – 2016-11 · Upper Gastrointestinal Bleeding
What this study did
NCT02767479 · Hamamatsu University
2012-07 – 2016-04 · H. Pylori Infection
What this study did
NCT01140828 · Chinese University of Hong Kong
2009-05 – 2015-06 · Osteoarthritis, Arthritis, Rheumatoid, Dyspepsia
What this study did
NCT03658473 · Galeno Desenvolvimento de Pesquisas Clínicas
2014-11-12 – 2015-02-04 · Gastric Lesion
What this study did
NCT04001400 · Seoul National University Hospital
2012-10-10 – 2014-05-21 · Esophageal Disease
What this study did
NCT02037477 · Takeda
2014-01 – 2014-03 · Healthy Volunteers
What this study did
NCT01391715 · Inje University
2011-08 – 2012-12 · Gastroesophageal Reflux Disease
What this study did
NCT00992589 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2009-11 – 2011-11 · Gastroesophageal Reflux
What this study did
NCT00787891 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2009-01 – 2011-01 · Gastroesophageal Reflux Disease (GERD)
What this study did
NCT01051388 · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
2008-08 – 2010-12 · Cardio-cerebrovascular Disease
What this study did
NCT00658528 · Eisai Inc.
2008-02 – 2010-01 · Gastroesophageal Reflux Disease (GERD)
What this study did
NCT00658775 · Eisai Inc.
2008-02 – 2010-01 · Gastroesophageal Reflux Disease (GERD)
What this study did
NCT00839306 · Eisai Inc.
2008-08 – 2010-01 · Gastroesophageal Reflux Disease (GERD)
What this study did
NCT00838526 · Eisai Inc.
2008-08-31 – 2009-12-31 · Gastroesophageal Reflux Disease (GERD)
What this study did
NCT00911534 · Eisai Inc.
2009-01 – 2009-10 · Symptomatic Gastroesophageal Reflux Disease (sGERD)
What this study did
NCT00658632 · Eisai Inc.
2008-02 – 2009-09 · Gastroesophageal Reflux Disease (GERD)
What this study did
NCT00236197 · Eisai Inc.
2005-10 – 2008-06 · Heartburn
What this study did
NCT00236184 · Eisai Inc.
2005-10 – 2008-06 · Heartburn
What this study did
NCT00165672 · Eisai Inc.
2005-05 – 2005-10 · Non-erosive Gastroesophageal Reflux Disease
What this study did
NCT00553449 · Janssen-Ortho Inc., Canada
2004-07 – 2005-09 · Gastroesophageal Reflux, Heartburn
What this study did
NCT00214552 · Associated Scientists to Help Minimize Allergies
2002-09 – 2005-03 · Asthma, Gastroesophageal Reflux Disease
What this study did
NCT00236392 · Janssen Pharmaceutica N.V., Belgium
2001-10 – 2002-10 · Gastroesophageal Reflux, Heartburn
What this study did
Phase 2/3 (4)
Other / comorbidity
NCT01398410 · Eisai Co., Ltd.
2011-12 – 2014-02 · Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin
What this study did
NCT00539240 · US Department of Veterans Affairs
2006-04 – 2011-11 · Gastroesophageal Reflux Disease
What this study did
NCT00204698 · University of Utah
2003-08 – 2006-05 · Laryngopharyngeal Reflux
What this study did
NCT00197418 · Hamamatsu University
started 2003-08 · Helicobacter Infections, Gastritis, Gastric Ulcer, Duodenal Ulcer
What this study did
Phase 2 (9)
Helicobacter pylori Infection
NCT06076694 · TenNor Therapeutics (Suzhou) Limited
2022-06-26 – 2022-09-20 · Helicobacter Pylori Infection
What this study did
NCT01513785 · Shanghai Jiao Tong University School of Medicine
2011-04 – 2012-01 · Functional Dyspepsia
What this study did
Other / comorbidity
NCT01202071 · Eisai Co., Ltd.
2010-09 – 2010-12 · Healthy
What this study did
NCT01136317 · Nantes University Hospital
2010-04 – 2010-07 · Gastroesophageal Reflux
What this study did
NCT00165841 · Eisai Inc.
2004-10 – 2008-06 · Gastroesophageal Reflux Disease
What this study did
NCT00199953 · Medical College of Wisconsin
2002-06 – 2007-12 · Postnasal Drainage
What this study did
NCT00222170 · University of Kansas
2005-05 – 2007-05 · Esophageal Reflux
What this study did
NCT00132496 · Eisai Inc.
2005-08 – 2006-07 · Gastroesophageal Reflux Disease
What this study did
Phase 1/2 (3)
Helicobacter pylori Infection
Other / comorbidity
NCT06630234 · Deciphera Pharmaceuticals, LLC
2024-12-10 – 2028-05 · Gastrointestinal Stromal Tumor (GIST)
What this study did
Phase 1 (78)
Helicobacter pylori Infection
NCT06337604 · TenNor Therapeutics Inc.
2017-10-10 – 2017-11-23 · Helicobacter Pylori Infection
What this study did
Other / comorbidity
NCT06899061 · AstraZeneca
2025-03-25 – 2028-05-19 · Advanced Solid Malignancies
What this study did
NCT07797478 · Genentech, Inc.
2026-08-28 – 2027-06-15 · Healthy Volunteers
What this study did
NCT07888569 · Dizal Pharmaceuticals
2026-10-23 – 2026-11-23 · Healthy
What this study did
NCT07597928 · Pfizer
2026-05-13 – 2026-09-01 · Healthy Adults, Healthy
What this study did
NCT07643272 · Hutchmed
2026-06-30 – 2026-08-31 · Healthy Participants
What this study did
NCT07339956 · China-Japan Friendship Hospital
2026-01-10 – 2026-08-30 · Gastrointestinal Bleeding
What this study did
NCT07838987 · Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
2023-12-21 – 2026-06-30 · Healthy
What this study did
NCT07563894 · Pfizer
2026-04-10 – 2026-06-26 · Healthy
What this study did
NCT07141381 · Voronoi, Inc
2025-08-27 – 2026-04-16 · Healthy
What this study did
NCT07284173 · Pfizer
2025-11-03 – 2025-12-18 · Healthy Adults
What this study did
NCT07329972 · Genentech, Inc.
2025-11-21 – 2025-12-14 · Healthy Volunteers
What this study did
NCT07171619 · SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
2025-08-21 – 2025-11-10 · Healthy
What this study did
NCT06399315 · Lomond Therapeutics Holdings, Inc.
2023-07-28 – 2025-08-26 · AML
What this study did
NCT06417229 · Celgene
2024-05-28 – 2025-02-19 · Healthy Participants
What this study did
NCT06105983 · Pfizer
2023-11-03 – 2024-07-19 · Healthy
What this study did
NCT05923411 · Pfizer
2023-07-11 – 2024-07-19 · Healthy Participants
What this study did
NCT06054464 · PMV Pharmaceuticals, Inc
2023-09-19 – 2024-02-06 · Healthy Volunteers
What this study did
NCT05918822 · Takeda
2023-07-25 – 2023-09-01 · Healthy Volunteers
What this study did
NCT05930119 · Hutchmed
2023-03-17 – 2023-08-28 · Intrahepatic Cholangiocarcinoma
What this study did
NCT05899829 · Bellus Health Inc. - a GSK company
2023-06-21 – 2023-08-08 · Cough, Healthy
What this study did
NCT05446142 · Pfizer
2022-07-01 – 2022-09-30 · Healthy
What this study did
NCT05571787 · Hutchmed
2022-07-13 – 2022-09-22 · Relapsed or Refractory Lymphoma
What this study did
NCT05330858 · Alumis Inc
2022-03-17 – 2022-09-20 · Pharmacokinetics
What this study did
NCT04564612 · Biogen
2020-09-28 – 2022-09-07 · Healthy Volunteers
What this study did
NCT05602597 · Hutchmed
2022-06-01 – 2022-08-06 · Relapsed or Refractory Lymphoma
What this study did
NCT04944771 · AstraZeneca
2021-07-26 – 2022-05-04 · Solid and Hematological Malignancies
What this study did
NCT04703868 · Yungjin Pharm. Co., Ltd.
2021-01-13 – 2021-06-14 · Gastroesophageal Reflux Disease
What this study did
NCT04565574 · Eisai Co., Ltd.
2020-10-16 – 2021-03-31 · Healthy Participants
What this study did
NCT04622358 · Addpharma Inc.
2020-12-05 – 2021-03-08 · Gastroesophageal Reflux Disease
What this study did
NCT04488016 · AstraZeneca
2020-06-24 – 2021-01-20 · Bioavailability, B-cell Lymphoid Cancer
What this study did
NCT04494243 · Addpharma Inc.
2020-08-28 – 2021-01-15 · Gastroesophageal Reflux Disease
What this study did
NCT04645940 · Hutchison Medipharma Limited
2020-09-24 – 2020-11-18 · Drug Interaction, Food-drug Interaction
What this study did
NCT04489797 · AstraZeneca
2020-07-20 – 2020-08-28 · Infectious Disease
What this study did
NCT02655614 · Genentech, Inc.
2016-05-31 – 2020-03-16 · Amyotrophic Lateral Sclerosis
What this study did
NCT04211545 · Celgene
2019-10-21 – 2019-12-26 · Healthy Volunteer
What this study did
NCT03530995 · Kadmon Corporation, LLC
2018-04-09 – 2019-02-08 · Drug-drug Interaction, Autoimmune Diseases, Fibrotic Disease
What this study did
NCT03290703 · Genentech, Inc.
2017-04-18 – 2018-10-25 · Healthy Volunteers
What this study did
NCT03237741 · Genentech, Inc.
2017-08-07 – 2017-12-14 · Amyotrophic Lateral Sclerosis
What this study did
NCT03220191 · Pfizer
2017-07-21 – 2017-09-26 · Healthy Volunteer
What this study did
NCT03130556 · Pfizer
2017-05-01 – 2017-07-21 · Healthy Volunteers
What this study did
Phase 4 (42)
Helicobacter pylori Infection
NCT05061732 · Shanghai Zhongshan Hospital
2021-09-30 – 2026-06-30 · Helicobacter Pylori Infection
What this study did
NCT03897244 · National Taiwan University Hospital
2019-05-30 – 2025-02-17 · Helicobacter Pylori Infection
What this study did
NCT05718609 · Second Affiliated Hospital, Zhejiang University, School of Medicine
2023-03-01 – 2024-06-30 · Helicobacter Pylori Infection
What this study did
NCT05419674 · Second Affiliated Hospital, Zhejiang University, School of Medicine
2022-08-01 – 2023-08-01 · Helicobacter Pylori Infection
What this study did
NCT05014685 · Shanghai Zhongshan Hospital
2021-08-20 – 2022-12-30 · Helicobacter Pylori Infection
What this study did
NCT05018923 · Shanghai Zhongshan Hospital
2021-08-24 – 2022-12-30 · Helicobacter Pylori Infection
What this study did
NCT05023577 · Shanghai Zhongshan Hospital
2021-08-26 – 2022-12-30 · Helicobacter Pylori Infection
What this study did
NCT04667299 · Shanghai Zhongshan Hospital
2020-12-20 – 2021-12-31 · Helicobacter Pylori Infection
What this study did
NCT04697186 · Xijing Hospital of Digestive Diseases
2021-01-07 – 2021-12-20 · Dyspepsia, Chronic Gastritis, Gastric Cancer, Helicobacter Pylori Infection
What this study did
NCT03616405 · Shandong University
2019-04-01 – 2020-04-30 · Helicobacter Pylori Infection
What this study did
NCT04132479 · Kirby Institute
2018-01-01 – 2019-04-09 · Helicobacter Pylori Infection
What this study did
NCT03521726 · Mackay Memorial Hospital
2018-05-11 – 2019-02-12 · Helicobacter Pylori Infection
What this study did
NCT02490839 · National Taiwan University Hospital
2015-07 – 2019-01 · Helicobacter Pylori Infection
What this study did
NCT02483715 · National Taiwan University Hospital
2015-07 – 2018-05 · Helicobacter Pylori Infection
What this study did
NCT03134378 · Universitas Indonesia
2016-10-03 – 2017-05-12 · Helicobacter Pylori Infection
What this study did
NCT02541786 · Kaohsiung Medical University
2015-01 – 2015-08 · Helicobacter Pylori Infection
What this study did
NCT03108287 · Kaohsiung Medical University Chung-Ho Memorial Hospital
2013-04-01 – 2015-02-28 · Helicobacter Pylori Infection
What this study did
NCT01219764 · American University of Beirut Medical Center
2010-10 – 2013-03 · Helicobacter Infections
What this study did
NCT01566643 · Buddhist Tzu Chi General Hospital
2011-01 – 2012-12 · Helicobacter Pylori Infection
What this study did
NCT01575899 · Buddhist Tzu Chi General Hospital
2007-12 – 2009-12 · Helicobacter Pylori Infection
What this study did
NCT00216450 · Janssen Cilag Pharmaceutica S.A.C.I., Greece
2004-10 – 2006-02 · Helicobacter Infections, Bacterial Infections
What this study did
Other / comorbidity
NCT07471867 · Yonsei University
2026-04-02 – 2028-07-12 · Chronic Coronary Syndrome
What this study did
NCT05191888 · Kaohsiung Medical University
2021-08-06 – 2024-12-31 · Helicobacter Pylori Eradication
What this study did
NCT05879029 · Tongji Hospital
2023-07-01 – 2024-12 · Laryngopharyngeal Reflux
What this study did
NCT04157881 · Population Health Research Institute
2020-01-03 – 2022-01-18 · Atrial Fibrillation, Venous Thromboembolism
What this study did
NCT02986685 · Xijing Hospital of Digestive Diseases
2016-11 – 2017-11 · Refractory Reflux Esophagitis
What this study did
NCT01860482 · Chong Kun Dang Pharmaceutical
2013-04 – 2015-05 · Reflux Esophagitis
What this study did
NCT02605395 · GlaxoSmithKline
2014-03-22 – 2014-03-30 · Gastrointestinal Diseases
What this study did
NCT02446483 · GlaxoSmithKline
2014-03-19 – 2014-03-26 · Gastrointestinal Diseases
What this study did
NCT01922765 · The Catholic University of Korea
2013-08 – 2014-02 · Gastritis, Gastric Ulcer, and Duodenal Ulcer
What this study did
NCT00844675 · The Catholic University of Korea
2007-10 – 2012-03 · Early Gastric Adenocarcinoma, Adenocarcinoma, Tubular
What this study did
NCT00251732 · University of Arizona
2005-03 – 2010-05 · Gastroesophageal Reflux Disease
What this study did
NCT00861640 · Kaohsiung Medical University Chung-Ho Memorial Hospital
2009-03 – 2010-04 · Nonvariceal Upper Gastrointestinal Bleeding
What this study did
NCT00838682 · The Catholic University of Korea
2006-04 – 2009-03 · Peptic Ulcer Hemorrhage
What this study did
NCT00354757 · National Taiwan University Hospital
2005-06 – 2008-12 · GERD
What this study did
NCT01008696 · Janssen Korea, Ltd., Korea
2007-05 – 2008-08 · Reflux Esophagitis
What this study did
NCT00220857 · Temple University
2005-09 – 2007-09 · Normal Subjects
What this study did
NCT00304421 · VA Greater Los Angeles Healthcare System
2004-01 – 2007-09 · Gastroesophageal Reflux Disease
What this study did
NCT00287391 · University of North Carolina
2004-09 – 2006-12 · Insomnia, GERD
What this study did
NCT00216489 · Janssen Cilag Pharmaceutica S.A.C.I., Greece
2003-03 – 2005-11 · Gastroesophageal Reflux, Heartburn
What this study did
NCT00237367 · PriCara, Unit of Ortho-McNeil, Inc.
est. completion 2005-04 · Gastroesophageal Reflux
What this study did
Early phase / not applicable (20)
Helicobacter pylori Infection
NCT07788053 · Chih-An Shih, MD
2026-09-01 – 2029-09-01 · Helicobatcer Pylori, First-Line Eradication
What this study did
NCT07358130 · Kaohsiung Medical University
2025-10-21 – 2027-12-31 · Helicobacter Pylori Infection
What this study did
NCT07211880 · Zero Helicobacter IGAN Network
2019-12-05 – 2023-03-21 · H.Pylori, Gastric Cancer, H Pylori Eradication
What this study did
NCT04923113 · Second Affiliated Hospital, Zhejiang University, School of Medicine
2021-06-28 – 2023-01-18 · Helicobacter Pylori Infection
What this study did
NCT05152004 · Chang Gung Memorial Hospital
2018-09-01 – 2022-02-28 · Helicobacter Pylori Infection
What this study did
NCT02547025 · Kaohsiung Veterans General Hospital.
2012-08-01 – 2021-10-31 · Helicobacter Pylori Infection
What this study did
NCT03802318 · Chang Gung Memorial Hospital
2019-01-02 – 2020-12 · Helicobacter Pylori Infection, Helicobacter Gastritis, Helicobacter-Associated Pyloric Ulcer
What this study did
Other / comorbidity
NCT06349486 · Kaohsiung Medical University
2023-11-28 – 2026-12-31 · Helicobacter Pylori Eradication
What this study did
NCT06481371 · Nanjing First Hospital, Nanjing Medical University
2024-06-30 – 2025-04-30 · Functional Dyspepsia, Depression
What this study did
NCT03320538 · Jiangxi University of Traditional Chinese Medicine
2017-07-10 – 2020-09-17 · Peptic Ulcer Disease
What this study did
NCT02826408 · Jordan Collaborating Cardiology Group
2016-10 – 2018-03 · Signs and Symptoms
What this study did
NCT00234117 · Ponce Gastroenterology Research
started 2005-07 · Bronchial Asthma, Gastroesophageal Reflux
What this study did
NCT01237353 · University of California, San Francisco
2011-03 – 2011-07 · Pharmacodynamic
What this study did
NCT00539786 · Samsung Medical Center
2006-03 – 2011-04 · Gastroesophageal Reflux Disease
What this study did
NCT01037491 · Taipei Veterans General Hospital, Taiwan
2009-10 – 2010-12 · Gastric Ulcer, Duodenal Ulcer
What this study did
NCT01139645 · American University of Beirut Medical Center
2009-10 – 2010-07 · Calcium Metabolism Disorders
What this study did
NCT00517114 · Hospital Authority, Hong Kong
2005-01 – 2008-12 · Gastroesophageal Reflux, Laryngitis
What this study did
NCT00681005 · National Taiwan University Hospital
2006-04 – 2008-01 · GERD
What this study did
NCT00162877 · National Taiwan University Hospital
2004-06 – 2005-04 · Peptic Ulcer With H. Pylori Infection, Gastritis With H. Pylori Infection
What this study did
Used as active comparator (17)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (1)
Other / comorbidity
NCT04215653 · Sihuan Pharmaceutical Holdings Group Ltd.
2020-01-20 – 2021-02-28 · Duodenal Ulcer,DU
What this study did
Phase 2/3 (1)
Other / comorbidity
NCT02847455 · Livzon Pharmaceutical Group Inc.
2008-08 – 2009-10 · Duodenal Ulcer
What this study did
Phase 2 (3)
Other / comorbidity
NCT05604261 · Xuanzhu Biopharmaceutical Co., Ltd.
2022-12 – 2024-03 · Reflux Esophagitis, Gastroesophageal Reflux, Esophagitis, Esophageal Motility Disorders, Deglutition Disorders, Esophageal Diseases, Gastrointestinal Diseases
What this study did
NCT04503629 · Sihuan Pharmaceutical Holdings Group Ltd.
2018-10-09 – 2019-05-17 · Duodenal Ulcer,DU
What this study did
NCT02463643 · Zeria Pharmaceutical
2015-05 – 2017-03 · Esophagitis, Reflux
What this study did
Phase 1 (5)
Other / comorbidity
NCT04471922 · Sihuan Pharmaceutical Holdings Group Ltd.
2019-03-21 – 2019-03-28 · Healthy Volunteers
What this study did
NCT00649194 · Mylan Pharmaceuticals Inc
2003-08 – 2003-08 · Healthy
What this study did
NCT00649493 · Mylan Pharmaceuticals Inc
2003-05 – 2003-06 · Healthy
What this study did
NCT00648349 · Mylan Pharmaceuticals Inc
2003-05 – 2003-06 · Healthy
What this study did
Phase 4 (6)
Helicobacter pylori Infection
NCT05014334 · Xijing Hospital of Digestive Diseases
2021-12-01 – 2022-06-30 · Helicobacter Pylori Infection, Chronic Gastritis
What this study did
NCT03908619 · Changi General Hospital
2019-04-16 – 2021-03-31 · Helicobacter Pylori Infection
What this study did
NCT03658733 · Shandong University
2018-12-15 – 2019-10-31 · Helicobacter Pylori Infection
What this study did
Other / comorbidity
NCT07122024 · Second Affiliated Hospital, Zhejiang University, School of Medicine
2024-02-19 – 2025-12-30 · Helicobacter Pylori
What this study did
NCT03037606 · Neutec Ar-Ge San ve Tic A.Ş
2017-08-01 – 2018-12-11 · Gastroesophageal Reflux Disease
What this study did
NCT02638584 · Il-Yang Pharm. Co., Ltd.
2015-12 – 2018-03 · Gastric Cancer
What this study did
Early phase / not applicable (1)
Other / comorbidity
NCT06004401 · Shanghai Changzheng Hospital
2023-08-20 – 2025-12-31 · The Eradication Rate of Helicobacter Pylori
What this study did
Appears in other studies (7)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 3 (1)
Helicobacter pylori Infection
NCT02407119 · National Cancer Center, Korea
2003-06 – 2030-06 · Helicobacter Pylori Infection, Early Gastric Cancer, Endoscopic Resection
What this study did
Phase 1 (5)
Other / comorbidity
NCT07608666 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
2026-07-20 – 2026-12 · Myelofibrosis
What this study did
NCT03789032 · Akebia Therapeutics
2018-10-03 – 2018-11-19 · Drug Interaction Potentiation, Pharmacokinetics
What this study did
NCT03143166 · Boehringer Ingelheim
2017-05-22 – 2017-08-02 · Non-alcoholic Fatty Liver Disease
What this study did
NCT01772290 · Genentech, Inc.
2013-02 – 2013-05 · Healthy Volunteer
What this study did
Phase 4 (1)
Other / comorbidity
NCT00125736 · Eisai Co., Ltd.
2005-08-01 – 2007-04-19 · Stomach Ulcer
What this study did

Competitive landscape

Other H+/K+-ATPase (gastric proton pump) drugs

Esomeprazole. Compare all 2 H+/K+-ATPase (gastric proton pump) drugs

1 other tracked programme targets this mechanism, none of them ahead of this one.

This drug's own stage for Helicobacter pylori Infection: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Rabeprazole (Aciphex): this drugApprovedSmall moleculeH+/K+-ATPase (gastric proton pump)not yet gradedNo reviewed efficacy summary in this indication
Esomeprazole (Nexium)ApprovedSmall moleculeH+/K+-ATPase (gastric proton pump)not yet gradedNo reviewed efficacy summary in this indication
Omeprazole, Amoxicillin, And Rifabutin (Talicia)ApprovedSmall moleculeH. pylori eradication (PPI + amoxicillin + rifabutin)Reliable signal
NCT03198507: Number of Participants With Eradication of H. Pylori (43-71 days after initiation of treatment): RHB-105 191 Participants | Active Comparator 131 Participants
NCT01980095: The Occurrence of H. Pylori Eradication as Confirmed Via 13C UBT Testing (28-56 days after completion of treatment): RHB-105 — H. pylori eradication success: 59 Participants; H. pylori eradication failure: 7 Participants | Placebo — H. pylori eradication success: 1 Participants; H. pylori eradication failure: 36 Participants

Upcoming events

(7 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Aciphex (Rabeprazole) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (2)
November 2026 (1)
Phase 1HealthyRecruiting
Est. primary completion 2026-11-23 · NCT07888569 · CT.gov ↗
What to watch
December 2026 (1)
Early phase / not applicableHelicobacter Pylori EradicationRecruiting
Est. primary completion 2026-12-31 · NCT06349486 · CT.gov ↗
What to watch
2027 (2)
June 2027 (1)
Phase 1Healthy VolunteersRecruiting
Est. primary completion 2027-06-15 · NCT07797478 · CT.gov ↗
What to watch
November 2027 (1)
Early phase / not applicableHelicobacter pylori InfectionRecruiting
Est. primary completion 2027-11-15 · NCT07358130 · CT.gov ↗
What to watch
2028 (2)
May 2028 (1)
Phase 1/2Gastrointestinal Stromal Tumor (GIST)Recruiting
Est. primary completion 2028-05 · NCT06630234 · CT.gov ↗
What to watch
July 2028 (1)
Phase 4Chronic Coronary SyndromeRecruiting
Est. primary completion 2028-07-12 · NCT07471867 · CT.gov ↗
What to watch
2029 (1)
September 2029 (1)
Early phase / not applicableHelicobacter pylori InfectionNot yet recruiting
Est. primary completion 2029-09-01 · NCT07788053 · CT.gov ↗
What to watch

See the full readout calendar ↗